Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

442

Figures (1-3)

Tables (1-1)

Sum=545

Publishing Process of This Article

Item

Count

Browse

Download

Sum=43

May 15, 2024 (publication date) through Jun 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. May 15, 2024; 16(5): 2113-2122
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2113

Table 1 Characteristic features of study populations

CRC: Colorectal cancer; CRC⁺: Colorectal cancer with severe coronavirus disease 2019.

Citation: Wang JF, Yang XX, Zhang J, Zheng Y, Zhang FQ, Shi XF, Wang YL. Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19. World J Gastrointest Oncol 2024; 16(5): 2113-2122
URL: https://www.wjgnet.com/1948-5204/full/v16/i5/2113.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.2113